| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sec'y; Chief Compliance & G.c. | Sec'y; Chief Compliance & G.c.
1 company
Scott Terrillion last filed a Form 4 in February 2025, as Sec'y; Chief Compliance & G.c. at TVRD. From December 2018 to February 2025, the filings on record show 0 open-market purchases and 19 sales. Scott Terrillion's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Scott Terrillion a strong insider score of 90/100, based on 12 past trades. Over a 12-month horizon, all 12 of those trades were profitable, with an average 12-month return of +61.3%.
At the last filing, the largest reported position was 7,190 shares of TVRD. The TVRD filings lean toward selling, a net 56,064 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 1,972 | $10.29 | $20,291.88 | -1.9% | -23.4% | -4.1% | |
| Aug 30, 2021 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 1,759 | $14.20 | $24,977.80 | -2.4% | -15.2% | -29.8% | |
| Mar 5, 2021 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 3,090 | $17.98 | $55,558.20 | -5.7% | - | - | |
| Feb 25, 2021 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 4,004 | $19.33 | $77,397.32 | -8.3% | - | - | |
| Dec 30, 2020 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 1,946 | $15.30 | $29,773.80 | -4.4% | - | - | |
| Apr 21, 2020 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 2,721 | $15.56 | $42,338.76 | -6.6% | - | - | |
| Dec 4, 2019 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 3,980 | $17.05 | $67,859.00 | -19.2% | - | - | |
| May 29, 2019 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 2,303 | $21.38 | $49,238.14 | -15.6% | - | - | |
| Dec 28, 2018 | TVRD Tvardi Therapeutics, Inc. | Sec'y; Chief Compliance & G.c. | Sell | 3,100 | $12.51 | $38,781.00 | -32.7% | - | - |